08/14/2025
4:07 PM | Commodore Capital LP (Filed by)
Relay Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
07/30/2025
3:53 PM | Adams Brian (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2025
3:54 PM | Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2025
3:54 PM | Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2025
3:54 PM | Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
3:12 PM | Relay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2025
3:15 PM | Mazumdar Claire (Reporting)
Relay Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/06/2025
4:50 PM | Relay Therapeutics (Issuer)
Rubin Jami (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:51 PM | Murcko Mark (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:51 PM | Kathiresan Sekar (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:51 PM | INGRAM DOUGLAS S (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RLAY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Relay Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/06/2025
4:52 PM | Borisy Alexis (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:52 PM | HILL LINDA A (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:15 PM | Relay Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2025
7:23 PM | Adams Brian (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
7:24 PM | Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
7:24 PM | Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
7:25 PM | Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2025
3:10 PM | Relay Therapeutics (Filer)
| Form DEFA14A | |
04/23/2025
3:15 PM | Relay Therapeutics (Filer)
| Form ARS | |
04/23/2025
3:05 PM | Relay Therapeutics (Filer)
| Form DEF 14A | |
03/20/2025
5:13 PM | Point72 Asset Management, L.P. (Filed by)
Relay Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/26/2025
3:10 PM | Relay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
7:56 PM | Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Relay Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/30/2025
8:02 PM | Adams Brian (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
8:06 PM | Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
8:10 PM | Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
8:16 PM | Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
6:01 PM | Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:03 PM | Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
3:04 PM | Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/14/2025
8:00 PM | Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
8:00 PM | Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
8:00 PM | Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
8:00 PM | Adams Brian (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
8:00 PM | Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
7:30 AM | Relay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
7:35 PM | Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:05 PM | Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:05 PM | Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Why Trump’s “Smart Dollar” could rewrite the rules (Ad) MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar
Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now. Get the three steps to take this month to put yourself on the right side of this $30 trillion money |
12/31/2024
3:05 PM | Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:05 PM | Adams Brian (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:01 PM | Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
3:18 PM | Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
6:00 AM | Relay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:10 PM | Relay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
3:07 PM | Adams Brian (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
3:08 PM | Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
3:09 PM | Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
3:09 PM | Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
3:05 PM | Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:45 PM | Relay Therapeutics (Filer)
| Form 424B5 | |
09/11/2024
3:49 PM | Relay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
3:43 PM | Relay Therapeutics (Filer)
| Form 424B5 | |
09/09/2024
7:00 AM | Relay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
